TSE:6078 stock news
This page provides real-time market news, earnings updates, and company announcements related to Value HR Co., Ltd. (TSE:6078).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-27 15:25 JST
BWXT Surges 13% Amid Institutional Investors Reducing Holdings
101 finance2026-03-27 03:12:44
Huntsman Soars on Inflows Despite Crashing Technicals
101 finance2026-03-27 03:12:40
ADMA Biologics: Solid Core Strength Meets Challenging Technical Indicators
101 finance2026-03-27 03:18:48
Planet Labs: Retail Buys, Institutions Sell
101 finance2026-03-27 03:21:45
On Holding's Analyst Buy Rating Clashes With Bearish Reality
101 finance2026-03-27 03:21:45
Progress Software: Wall Street Invests Amid Falling Prices
101 finance2026-03-27 03:21:46
LUNR: Strong Money Flows Clash with Bearish Chart
101 finance2026-03-27 03:21:46
CAVA Group Encounters Negative Trends as Major Investors Withdraw
101 finance2026-03-27 03:24:49
Summit Therapeutics Rallies 16% as Institutions Sell
101 finance2026-03-27 03:24:48
AgomAb Analysts Say Buy, but Track Record Says No
101 finance2026-03-27 03:27:49
Worthington Fundamentals Hold, But Big Money Fled
101 finance2026-03-27 03:27:50
NETGEAR: Smart Money Buys as Analysts Wait
101 finance2026-03-27 03:30:53
monday.com: Big Money Flees While Analysts Cheer
101 finance2026-03-27 03:33:34
NAT.N Surges 11% — But Institutions Are Selling
101 finance2026-03-27 03:36:39
ProFrac Fundamentals Soar While Institutions Flee
101 finance2026-03-27 03:36:40
Mesoblast Analysts Say Buy, Charts Warn of Danger
101 finance2026-03-27 03:36:40
Rani Therapeutics Narrows Loss Yet Stock Plummets 11%
101 finance2026-03-27 03:36:39
BitGo reported a $50 million loss in Q4, with shares dropping over 8% on Thursday
ForesightNews2026-03-27 04:09:32
Meta Stock Plunges: Court Verdicts and AI Spending Risks
101 finance2026-03-27 04:09:43
Zenas BioPharma completes $300 million financing: issuance of convertible senior notes and common stock to accelerate autoimmune drug development Biopharmaceutical company Zenas BioPharma announced the completion of a concurrent public offering of 2.50% convertible senior notes due 2032 and common stock, raising a total of $300 million.
老虎证券2026-03-27 04:16:22
SDGE Power Outage: How Infrastructure Resilience Impacts Stock Stability
101 finance2026-03-27 05:06:41
OpenAI Faces Bankruptcy Risk as $14 Billion Burn Rate Clashes With 108% Growth Delusion
101 finance2026-03-27 05:48:47
2 "Magnificent Seven" Stocks That Have Dropped 10% to 23% and Are Worth Buying Now
101 finance2026-03-27 06:00:51
Tesla's 6-Door Gamble: Why Execution Risks Are Discounting the Real Family EV Alpha
101 finance2026-03-27 06:12:42
On Holding's Analyst Buy Rating Clashes With Bearish Reality
101 finance2026-03-27 03:21:45
Progress Software: Wall Street Invests Amid Falling Prices
101 finance2026-03-27 03:21:46
LUNR: Strong Money Flows Clash with Bearish Chart
101 finance2026-03-27 03:21:46
CAVA Group Encounters Negative Trends as Major Investors Withdraw
101 finance2026-03-27 03:24:49
Summit Therapeutics Rallies 16% as Institutions Sell
101 finance2026-03-27 03:24:48
AgomAb Analysts Say Buy, but Track Record Says No
101 finance2026-03-27 03:27:49
Worthington Fundamentals Hold, But Big Money Fled
101 finance2026-03-27 03:27:50
NETGEAR: Smart Money Buys as Analysts Wait
101 finance2026-03-27 03:30:53
monday.com: Big Money Flees While Analysts Cheer
101 finance2026-03-27 03:33:34
NAT.N Surges 11% — But Institutions Are Selling
101 finance2026-03-27 03:36:39
ProFrac Fundamentals Soar While Institutions Flee
101 finance2026-03-27 03:36:40
Mesoblast Analysts Say Buy, Charts Warn of Danger
101 finance2026-03-27 03:36:40
Rani Therapeutics Narrows Loss Yet Stock Plummets 11%
101 finance2026-03-27 03:36:39
BitGo reported a $50 million loss in Q4, with shares dropping over 8% on Thursday
ForesightNews2026-03-27 04:09:32
Meta Stock Plunges: Court Verdicts and AI Spending Risks
101 finance2026-03-27 04:09:43
Zenas BioPharma completes $300 million financing: issuance of convertible senior notes and common stock to accelerate autoimmune drug development Biopharmaceutical company Zenas BioPharma announced the completion of a concurrent public offering of 2.50% convertible senior notes due 2032 and common stock, raising a total of $300 million.
老虎证券2026-03-27 04:16:22
SDGE Power Outage: How Infrastructure Resilience Impacts Stock Stability
101 finance2026-03-27 05:06:41
OpenAI Faces Bankruptcy Risk as $14 Billion Burn Rate Clashes With 108% Growth Delusion
101 finance2026-03-27 05:48:47
2 "Magnificent Seven" Stocks That Have Dropped 10% to 23% and Are Worth Buying Now
101 finance2026-03-27 06:00:51
Tesla's 6-Door Gamble: Why Execution Risks Are Discounting the Real Family EV Alpha
101 finance2026-03-27 06:12:42
TSE:6078 stock price change
On the last trading day, TSE:6078 stock closed at 1450.00 JPY, with a price change of 0.62% for the day.
Trade stock perpsTSE:6078 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more